您当前所在的位置:首页 > 产品中心 > 产品信息
Drospirenone_分子结构_CAS_67392-87-4)
点击图片或这里关闭

Drospirenone

产品号 DB01395 公司名称 DrugBank
CAS号 67392-87-4 公司网站 http://www.ualberta.ca/
分子式 C24H30O3 电 话 (780) 492-3111
分子量 366.4932 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 1206

产品价格信息

请登录

产品别名

标题
Drospirenone
IUPAC标准名
(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.0^{2,4}.0^{5,10}.0^{14,19}.0^{16,18}]nonadecane-15,2'-oxolan]-5-ene-5',7-dione
IUPAC传统名
drospirenone
别名
Drospirenonum [inn-latin]
DRSP
Drospirenona [inn-spanish]
6β,7β,15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17 carbolactone

产品登记号

PubChem CID 68873
CAS号 67392-87-4
PubChem SID 46507653

产品性质

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Drospirenone is a synthetic progestin that is an analog to spironolactone. It is found in a number of birth control formulations. Drospirenone differs from other synthetic progestins in that its pharmacological profile in preclinical studies shows it to be closer to the natural progesterone. As such it has anti-mineralocorticoid properties, counteracts the estrogen-stimulated activity of the renin-angiotensin-aldosterone system, and is not androgenic.
Indication For the prevention of pregnancy in women who elect an oral contraceptive.
Pharmacology Drospirenone differs from other synthetic progestins in that its pharmacological profile in preclinical studies shows it to be closer to the natural progesterone. As such it has anti-mineralocorticoid properties, counteracts the estrogen-stimulated activity of the renin-angiotensin-aldosterone system, and is not androgenic.
Affected Organisms
Humans and other mammals
Biotransformation Extensively metabolized following oral or intravenous administration. The two major metabolites are inactive and are formed independent of the CYP450 enzyme system. The metabolites are the acid form of drospirenone formed by opening of the lactone ring and the 4,5-dihydro-drospirenone-3-sulfate.
Absorption Oral bioavailability is approximately 76%.
Half Life 30 hours
Protein Binding 97%
References
Krattenmacher R: Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000 Jul;62(1):29-38. [Pubmed]
External Links
Wikipedia

参考文献

  • Krattenmacher R: Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000 Jul;62(1):29-38. Pubmed